1 | would | 22,264 |
2 | -cm/y | 3 |
3 | don´t | 3 |
4 | -cer-induced | 2 |
5 | -barriers | 1 |
6 | -bphtatpe | 1 |
7 | -dimethyl-3,3'-dinitro-2,2'-azobipyridine | 1 |
8 | -donors | 1 |
9 | -n-ethyl-4,5-dihydro-1h-pyrazole-1-carbothioamide | 1 |
10 | -nsaids | 1 |
11 | -precursors | 1 |
12 | -sensitizers | 1 |
13 | -thiosemicarbazone | 1 |
14 | -this | 1 |
15 | .iptc | 1 |
16 | .ultrafiltration-induced | 1 |
17 | /scleroderma | 1 |
18 | 3,3-diarylcyclopropenes | 1 |
19 | 3gcs | 1 |
20 | 8062 | 1 |
21 | alkan-1-ols | 1 |
22 | and¿the | 1 |
23 | autistics | 1 |
24 | bronchoreactivity | 1 |
25 | c165s | 1 |
26 | camponotini | 1 |
27 | channelrhodopsins | 1 |
28 | controlled/well-controlled | 1 |
29 | d-amphetamines | 1 |
30 | existto | 1 |
31 | fggs | 1 |
32 | glutamatergically | 1 |
33 | home-tf | 1 |
34 | hypertriglycaemia | 1 |
35 | imidazolines | 1 |
36 | mechanocardiograms | 1 |
37 | member-to | 1 |
38 | methyl-β-cyclodextrins | 1 |
39 | mid-gray | 1 |
40 | mifepritone | 1 |
41 | mpg-may | 1 |
42 | mv/ph | 1 |
43 | n-pufas | 1 |
44 | ofamerica | 1 |
45 | ofgundelia | 1 |
46 | oligodeoxyadenylates | 1 |
47 | palmitates | 1 |
48 | patient-days-should | 1 |
49 | results-to | 1 |
50 | single-mindedly | 1 |
51 | strategiesto | 1 |
52 | substituions | 1 |
53 | supplementation-associated | 1 |
54 | tpurs | 1 |
55 | unbiased.we | 1 |
56 | unthinkingly | 1 |
57 | uptake-would | 1 |
58 | xylitol-an | 1 |
1 | -barriers | 1 |
2 | -bphtatpe | 1 |
3 | -cer-induced | 2 |
4 | -cm/y | 3 |
5 | -dimethyl-3,3'-dinitro-2,2'-azobipyridine | 1 |
6 | -donors | 1 |
7 | -n-ethyl-4,5-dihydro-1h-pyrazole-1-carbothioamide | 1 |
8 | -nsaids | 1 |
9 | -precursors | 1 |
10 | -sensitizers | 1 |
11 | -thiosemicarbazone | 1 |
12 | -this | 1 |
13 | .iptc | 1 |
14 | .ultrafiltration-induced | 1 |
15 | /scleroderma | 1 |
16 | 3,3-diarylcyclopropenes | 1 |
17 | 3gcs | 1 |
18 | 8062 | 1 |
19 | alkan-1-ols | 1 |
20 | and¿the | 1 |
21 | autistics | 1 |
22 | bronchoreactivity | 1 |
23 | c165s | 1 |
24 | camponotini | 1 |
25 | channelrhodopsins | 1 |
26 | controlled/well-controlled | 1 |
27 | d-amphetamines | 1 |
28 | don´t | 3 |
29 | existto | 1 |
30 | fggs | 1 |
31 | glutamatergically | 1 |
32 | home-tf | 1 |
33 | hypertriglycaemia | 1 |
34 | imidazolines | 1 |
35 | mechanocardiograms | 1 |
36 | member-to | 1 |
37 | methyl-β-cyclodextrins | 1 |
38 | mid-gray | 1 |
39 | mifepritone | 1 |
40 | mpg-may | 1 |
41 | mv/ph | 1 |
42 | n-pufas | 1 |
43 | ofamerica | 1 |
44 | ofgundelia | 1 |
45 | oligodeoxyadenylates | 1 |
46 | palmitates | 1 |
47 | patient-days-should | 1 |
48 | results-to | 1 |
49 | single-mindedly | 1 |
50 | strategiesto | 1 |
51 | substituions | 1 |
52 | supplementation-associated | 1 |
53 | tpurs | 1 |
54 | unbiased.we | 1 |
55 | unthinkingly | 1 |
56 | uptake-would | 1 |
57 | would | 22,264 |
58 | xylitol-an | 1 |
1 | 8062 | 1 |
2 | ofamerica | 1 |
3 | ofgundelia | 1 |
4 | hypertriglycaemia | 1 |
5 | /scleroderma | 1 |
6 | .iptc | 1 |
7 | .ultrafiltration-induced | 1 |
8 | -cer-induced | 2 |
9 | controlled/well-controlled | 1 |
10 | supplementation-associated | 1 |
11 | patient-days-should | 1 |
12 | would | 22,264 |
13 | uptake-would | 1 |
14 | -n-ethyl-4,5-dihydro-1h-pyrazole-1-carbothioamide | 1 |
15 | and¿the | 1 |
16 | -dimethyl-3,3'-dinitro-2,2'-azobipyridine | 1 |
17 | mifepritone | 1 |
18 | -thiosemicarbazone | 1 |
19 | -bphtatpe | 1 |
20 | unbiased.we | 1 |
21 | home-tf | 1 |
22 | mv/ph | 1 |
23 | camponotini | 1 |
24 | xylitol-an | 1 |
25 | member-to | 1 |
26 | results-to | 1 |
27 | strategiesto | 1 |
28 | existto | 1 |
29 | c165s | 1 |
30 | n-pufas | 1 |
31 | 3gcs | 1 |
32 | autistics | 1 |
33 | -nsaids | 1 |
34 | 3,3-diarylcyclopropenes | 1 |
35 | imidazolines | 1 |
36 | d-amphetamines | 1 |
37 | oligodeoxyadenylates | 1 |
38 | palmitates | 1 |
39 | fggs | 1 |
40 | -this | 1 |
41 | alkan-1-ols | 1 |
42 | mechanocardiograms | 1 |
43 | methyl-β-cyclodextrins | 1 |
44 | channelrhodopsins | 1 |
45 | substituions | 1 |
46 | -barriers | 1 |
47 | -sensitizers | 1 |
48 | -donors | 1 |
49 | -precursors | 1 |
50 | tpurs | 1 |
51 | don´t | 3 |
52 | -cm/y | 3 |
53 | mpg-may | 1 |
54 | mid-gray | 1 |
55 | single-mindedly | 1 |
56 | unthinkingly | 1 |
57 | glutamatergically | 1 |
58 | bronchoreactivity | 1 |